Winton Group’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $964K | Sell |
17,433
-3,362
| -16% | -$186K | 0.05% | 442 |
|
|
2025
Q1 | $1.01M | Sell |
20,795
-5,973
| -22% | -$289K | 0.06% | 417 |
|
|
2024
Q4 | $1.03M | Buy |
26,768
+785
| +3% | +$30.3K | 0.07% | 344 |
|
|
2024
Q3 | $1.17M | Buy |
+25,983
| New | +$1.17M | 0.08% | 210 |
|
|
2021
Q3 | – | Sell |
-5,431
| Closed | -$244K | – | 1456 |
|
|
2021
Q2 | $244K | Buy |
+5,431
| New | +$244K | 0.01% | 1279 |
|
|
2020
Q4 | – | Sell |
-32,854
| Closed | -$642K | – | 1477 |
|
|
2020
Q3 | $642K | Sell |
32,854
-5,757
| -15% | -$112K | 0.02% | 1006 |
|
|
2020
Q2 | $682K | Buy |
38,611
+828
| +2% | +$14.6K | 0.02% | 1112 |
|
|
2020
Q1 | $267K | Sell |
37,783
-52,073
| -58% | -$368K | 0.01% | 1193 |
|
|
2019
Q4 | $633K | Buy |
89,856
+52,732
| +142% | +$371K | 0.01% | 1180 |
|
|
2019
Q3 | $446K | Buy |
+37,124
| New | +$446K | 0.01% | 1127 |
|